Article info
PDFNeurological rarities
Memantine-induced chorea and dystonia
- Correspondence to Dr Letizia Goncalves Borges, Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, 320 East Superior Street, Searle 12-541, Chicago, IL 60611, USA; legb16{at}gmail.com
Citation
Memantine-induced chorea and dystonia
Publication history
- Accepted November 7, 2016
- First published December 7, 2016.
Online issue publication
February 28, 2018
Article Versions
- Previous version (18 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Parkinson’s disease: etiopathogenesis and treatment
- Long term motor complications of levodopa: clinical features, mechanisms, and management strategies
- ▼Memantine for dementia?
- GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects
- Dystonia and chorea in acquired systemic disorders
- Genetics and epigenetics of Alzheimer's disease
- Movement disorders in catatonia
- Levodopa-induced dyskinesia in Parkinson’s disease: clinical features, pathogenesis, prevention and treatment
- Sleep disturbance in movement disorders: insights, treatments and challenges
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease